Pfizer to invest $95m in French specialty vaccine company Valneva
US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms ... Read More
US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms ... Read More